First Time Loading...

Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 10.265 USD 1.63%
Updated: May 9, 2024

Balance Sheet

Balance Sheet Decomposition
Phathom Pharmaceuticals Inc

Current Assets 397.4m
Cash & Short-Term Investments 381.4m
Receivables 1.6m
Other Current Assets 14.4m
Non-Current Assets 16.4m
PP&E 3.6m
Other Non-Current Assets 12.8m
Current Liabilities 38.8m
Accounts Payable 12.6m
Accrued Liabilities 19.1m
Other Current Liabilities 7.1m
Non-Current Liabilities 447.8m
Long-Term Debt 437.7m
Other Non-Current Liabilities 10.2m

Balance Sheet
Phathom Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1
244
288
183
155
381
Cash Equivalents
1
244
288
183
155
381
Total Receivables
0
0
0
0
0
2
Accounts Receivables
0
0
0
0
0
2
Other Receivables
0
0
0
0
0
0
Inventory
0
0
0
0
0
1
Other Current Assets
0
12
4
3
5
13
Total Current Assets
1
256
291
187
161
397
PP&E Net
0
1
3
3
4
4
PP&E Gross
0
1
3
3
4
4
Accumulated Depreciation
0
0
0
1
2
2
Other Long-Term Assets
0
0
0
0
1
13
Total Assets
1
N/A
257
+28 478%
295
+15%
189
-36%
165
-13%
414
+151%
Liabilities
Accounts Payable
0
1
17
5
10
13
Accrued Liabilities
0
3
31
14
16
19
Short-Term Debt
2
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
7
0
0
7
Other Current Liabilities
0
0
0
0
0
0
Total Current Liabilities
2
4
56
19
26
39
Long-Term Debt
0
23
40
90
205
438
Other Liabilities
0
3
6
9
9
10
Total Liabilities
2
N/A
29
+1 227%
101
+245%
117
+16%
240
+104%
487
+103%
Equity
Common Stock
0
0
0
0
0
0
Retained Earnings
1
256
386
529
727
929
Additional Paid In Capital
0
484
580
602
652
856
Total Equity
1
N/A
228
N/A
194
-15%
72
-63%
75
N/A
73
+3%
Total Liabilities & Equity
1
N/A
257
+28 478%
295
+15%
189
-36%
165
-13%
414
+151%
Shares Outstanding
Common Shares Outstanding
26
25
29
31
42
58

See Also

Discover More